Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Electromed stock

Own Electromed stock in just a few minutes.

Electromed, Inc is a medical devices business based in the US. Electromed shares (ELMD) are listed on the NYSE MKT and all prices are listed in US Dollars. Electromed employs 120 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Electromed

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ELMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Electromed share price

Use our graph to track the performance of ELMD stocks over time.

Electromed shares at a glance

Information last updated 2021-04-30.
52-week range$8.10 - $19.73
50-day moving average $10.57
200-day moving average $10.14
Wall St. target price$18.00
PE ratio 24.0732
Dividend yield N/A (0%)
Earnings per share (TTM) $0.41

Buy Electromed shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Electromed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Electromed under- or over-valued?

Valuing Electromed stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Electromed's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Electromed's P/E ratio

Electromed's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Electromed shares trade at around 24x recent earnings.

Electromed's EBITDA

Electromed's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.2 million.

The EBITDA is a measure of a Electromed's overall financial performance and is widely used to measure a its profitability.

Electromed financials

Revenue TTM $33.1 million
Operating margin TTM 10.68%
Gross profit TTM $25.2 million
Return on assets TTM 6.57%
Return on equity TTM 12.18%
Profit margin 11.17%
Book value $3.74
Market capitalisation $85.2 million

TTM: trailing 12 months

Shorting Electromed shares

There are currently 281,628 Electromed shares held short by investors – that's known as Electromed's "short interest". This figure is 21.3% up from 232,087 last month.

There are a few different ways that this level of interest in shorting Electromed shares can be evaluated.

Electromed's "short interest ratio" (SIR)

Electromed's "short interest ratio" (SIR) is the quantity of Electromed shares currently shorted divided by the average quantity of Electromed shares traded daily (recently around 51112.159709619). Electromed's SIR currently stands at 5.51. In other words for every 100,000 Electromed shares traded daily on the market, roughly 5510 shares are currently held short.

However Electromed's short interest can also be evaluated against the total number of Electromed shares, or, against the total number of tradable Electromed shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Electromed's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Electromed shares in existence, roughly 30 shares are currently held short) or 0.0393% of the tradable shares (for every 100,000 tradable Electromed shares, roughly 39 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Electromed.

Find out more about how you can short Electromed stock.

Electromed share dividends

We're not expecting Electromed to pay a dividend over the next 12 months.

Electromed share price volatility

Over the last 12 months, Electromed's shares have ranged in value from as little as $8.1 up to $19.73. A popular way to gauge a stock's volatility is its "beta".

ELMD.US volatility(beta: 0.69)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Electromed's is 0.6884. This would suggest that Electromed's shares are less volatile than average (for this exchange).

Electromed overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site